|
NBPF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.084500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.360000E-02 |
| Normal-vs-Stage2 |
2.068800E-01 |
| Normal-vs-Stage3 |
5.66260000000041E-05 |
| Normal-vs-Stage4 |
9.770400E-04 |
| Stage1-vs-Stage2 |
9.633200E-01 |
| Stage1-vs-Stage3 |
1.565730E-02 |
| Stage1-vs-Stage4 |
3.978400E-02 |
| Stage2-vs-Stage3 |
1.143390E-01 |
| Stage2-vs-Stage4 |
1.906750E-01 |
| Stage3-vs-Stage4 |
8.535800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.983300E-04 |
| Normal-vs-AfricanAmerican |
7.443200E-01 |
| Normal-vs-Asian |
3.475600E-02 |
| Caucasian-vs-AfricanAmerican |
3.936200E-02 |
| Caucasian-vs-Asian |
8.241800E-01 |
| AfricanAmerican-vs-Asian |
6.976100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.171420E-04 |
| Normal-vs-Female |
8.232200E-01 |
| Male-vs-Female |
3.602900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.763630E-01 |
| Normal-vs-Extreme_Weight |
8.03650000000822E-05 |
| Normal-vs-Obese |
6.513500E-02 |
| Normal-vs-Extreme_Obese |
6.958200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.206800E-01 |
| Normal_Weight-vs-Obese |
9.389000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.899400E-01 |
| Extreme_Weight-vs-Obese |
5.442500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.271000E-01 |
| Obese-vs-Extreme_Obese |
3.024400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.651600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.378620E-01 |
| Normal-vs-Age(61-80Yrs) |
6.379000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.175780E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.186800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.582600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.073800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.986300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.467160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.985600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.524900E-03 |
| Normal-VS-Type2 PRCC |
2.997900E-02 |
| Normal-VS-KIRP CIMP |
3.104600E-03 |
| Normal-VS-Unclassified PRCC |
3.470600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.391400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.538200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.589400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.193600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.613000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.124030E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.634900E-04 |
| Normal-vs-N1 |
1.61542999999043E-05 |
| Normal-vs-N2 |
1.162190E-03 |
| N0-vs-N1 |
2.876200E-01 |
| N0-vs-N2 |
1.695160E-01 |
| N1-vs-N2 |
3.014600E-01 |
|
|
